NEWS
![[NewsPrime] C&R Research Signed A Contract With Trutino Biosciences To Conduct A Phase 1b Clinical Trial For An Immuno-oncology Drug Candidate](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[NewsPrime] C&R Research signed a contract with Trutino Biosciences to conduct a Phase 1b clinical trial for an immuno-oncology drug candidate
2024-10-14
C&R Research signed a contract to conduct a Phase 1b clinical trial for an immuno-oncology drug candidate, commissioned by Trutino…
[Yakup] C&R Research, CLOP, and Trial Informatics signed an MOU to ‘Innovate Ophthalmic Clinical Trials’
2024-10-08
C&R Research (CEO Moon-Tae Yoon), CLOP (Co-CEOs Sang-Jun Park and Hyun-Jun Kim), and Trial Informatics (Co-CEOs Kyung-Won Kim and Byung-In…
[MoneyToday] 10 years of experience in global CRO, Commit to advance ‘K-New Drugs’ into the global market
2024-10-06
C&R Research is, without a doubt, the top Contract Research Organization (CRO) in Korea. In terms of revenue, operating profit,…
[Yakup] MOU with Wonkwang University Dental Hospital and C&R SMO to ‘Strengthen Clinical Trials Research Cooperation’
2024-09-27
C&R Research, C&R SMO, and Wonkwang University Dental Hospital signed an MOU to ‘Strengthen Clinical Trials Research Cooperation’. Through this…
[Yakup] C&R Research works with NeuroBiogen on clinical trials for Alzheimer’s drug candidate ‘Tisolagiline’
2024-09-19
C&R Research successfully received approval from the MFDS (Ministry of Food and Drug Safety of the Republic of Korea) for…